The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Sees Q1 revenue $185M, consensus $221.59M. Executive Vice President and CFO Jamie Coogan said, “We are pleased with our financial execution in ...

Reports Q4 revenue $252.4M, consensus $244.95M. President and CEO Russell Low commented, “Axcelis (ACLS) exited the year on a strong note, with ...

Q4 2024 Management View CEO Paul Sarvadi highlighted that adjusted EPS for Q4 2024 was $0.05, with adjusted EBITDA at $23 million, surpassing the midpoint of expectations. Paid worksite employees ...

Bill Holdings reported Q2 FY25 earnings surpassing expectations, highlighting strong revenue growth and promising forward ...

Cloudflare reported earnings that not only beat analyst estimates but also exceeded its own forecasts, highlighting robust ...

ConocoPhillips (NYSE:COP) shares are trading higher after the company released fourth-quarter results. Here’s a breakdown of ...

Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least ...

Yum China Holdings, Inc. (NYSE:YUMC) shares are trading higher on Thursday after the fourth-quarter FY24 earnings result. The ...

Management introduced 2025 EPS guidance of $16.15 to $16.55, reflecting 4% to 7% growth, or 8% to 11% when excluding a 4% currency headwind. The guidance assumes flat industrial production growth. For ...

Snapchat (SNAP) reported its Q4 2024 earnings results today, posting beats on both earnings per share (EPS) and revenue ...

AMD’s Q4 2024 earnings report was released at the close of markets today. The tech company reported $7.7 billion in revenue, ...